Find-Health-Articles.com - making medical research available to everyone
Research article summary (published 30 Dec 2002):

Steroid-induced elevation of glucose in Alzheimer's disease: relationship to gender, apolipoprotein E genotype and cognition.

Full Abstract

Glucose and insulin may play an important role in the pathophysiology and symptomatology of Alzheimers disease (AD), and prior studies suggest interactions among glucose, insulin, gender and apolipoprotein E genotype. We analyzed the relationship between steroid-induced glucose elevation and gender, presence of the apolipoprotein E epsilon 4 (APOE-4) allele and cognition using data from a multicenter trial of prednisone therapy in AD. The low-dose prednisone regimen (initial dose:
20 mg/day, maintenance dose:
10 mg/day) caused a moderate increase in random blood glucose (mean post-baseline glucose 115 mg/dl). There was a significant interaction between rise in glucose, gender and presence of the APOE-4 allele. There was no important relationship between glucose and cognitive function at baseline or with prednisone treatment. Meta-analysis including data from three other AD trials showed a small influence of random blood glucose on cognitive scores. These results support a relationship between gender, apolipoprotein E genotype and glucose metabolism, but do not indicate that mild changes in glucose have an important impact on cognitive function.

 

Learn Faster Today      Improve your study skills

Author information

Author/s: Aisen, P S (PS); Berg, J D (JD); Craft, S (S); Peskind, E R (ER); Sano, M (M); Teri, L (L); Mulnard, R A (RA); Thomas, R G (RG); Thal, L J (LJ);

Affiliation: Department of Neurology, Georgetown University Medical Center, 1Bles Building, 3800 Reservoir Road NW, Washington, DC 20007, USA. psa@georgetown.edu

Grants: U01-AG10483 (Agency:United States NIA)

Journal and publication information

Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.

Journal: Psychoneuroendocrinology (Psychoneuroendocrinology), published in England. (Language: eng)

Reference: 2003-Jan; vol 28 (issue 1) : pp 113-20

Dates: Created 2002/11/26; Completed 2003/06/27; Revised 2007/11/14;

PMID: 12445840, status: MEDLINE (last retrieval date: 11/6/2008)

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article (including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Associated Chemicals: Apolipoprotein E4 (0) ; Apolipoproteins E (0) ; Blood Glucose (0) ; Placebos (0) ; Prednisone (53-03-2)

Related articles

This article has not been indexed for related articles as yet, however you can still use the live related article search links below.

See 100+ related articles.

See a large map of 100+ related articles.

© Advanogy.com 2003-2008 - All rights reserved. Terms of Use | Contact Us | Index